Trajan for Grace Davisil Silica and Chem Service Standards in Australia and New Zealand


May 01, 2016

Trajan Scientific and Medical (Trajan), together with Grace Discovery Sciences (Grace) are delighted to advise that from 1 May 2016, Trajan is the new point of contact for the Grace Davisil Silica business in Australia and New Zealand. Additionally Trajan have taken on representation for the Chem Service Analytical Standards range previously handled by Grace.

Ms Kellie Neagle (Grace Customer Service) will be continuing her role, joining the Trajan team supporting these products. Grace has a history of providing exceptional customer service and quality products, and with Trajan as a customer-oriented business we are confident that all of our customers will continue to receive support and technical expertise through Kellie and the Trajan Australia and New Zealand Team.

Also recently joining Trajan is Mr Tony Anissa (Chromatography Business Development Manager, Australia and New Zealand). Tony is a chromatography specialist, who has previously worked at Grace and is familiar with the SGE, Chem Service and Davisil product portfolios.

Trajan supplies innovative products to support work in the laboratory.

Australia and New Zealand
anz@trajanscimed.com

Media contact information
media@trajanscimed.com
+44 (0) 1244 403 100



Also in News

Trajan expands into Malaysia
Trajan expands into Malaysia

May 09, 2017

Trajan Scientific and Medical has expanded its organizational and global manufacturing footprint with the opening of a Penang Malaysia facility last month. Malaysia is the sixth manufacturing site for Trajan, building on operations in the USA (Austin TX, Raleigh NC, and San Diego, CA) and Australia (Melbourne VIC, and Adelaide SA).

Read More

Shedding new light on the humble glass slide
Shedding new light on the humble glass slide

May 08, 2017

Pathology in Practice looks into a simple but effective solution to stop tissue sections becoming detached and floating away when faced with harsh processing conditions typical of methods such as immunohistochemistry and in situ hybridization.

Read More

How to optimize clinical trials in the commercial context
How to optimize clinical trials in the commercial context

March 15, 2017

Elpis Barons, CEO Trajan Accelerator Group, shared her experience about optimizing clinical trials, at the Devices and Diagnostics Lab on 15 March 2017 at The Auditorium @ 452 Flinders, Melbourne, Victoria, Australia.

Read More